OpenResearchAlpha

Sage Open Chronic Disease · Jan 2026

Protocol for EVOLVE-HBV, a study to determine the prevalence and characteristics of chronic hepatitis B virus infection in KwaZulu-Natal, South Africa, to inform interventions for diagnosis, treatment and prevention

Motswedi Andersonh-index 13, Tongai G. Maponga, Janine Upton, Gloria Sukali, Lusanda Mazibuko, Kathy Baisley, Theresa Smit, Elizabeth Waddilove, Marion Delphin, Dickman Gareta, Nikiwe Mbatha, Landiwe Ndimande, Njabulo Dayi, Gregory Ording-Jespersen, Njabulo Myeni, Busangani Ngwenya, Nondumiso Mpanza, Katya Govender, Ngcebo Mhlongo, Guy Harling, Alasdair Leslie, Nomathamsanqa Majozi, Dumisani Siwela, Xanthe Hunt, Bongiwe Ndlovu, Lulama Mthethwa, Nokukhanya Msomi, M. Azim Ansari, Resign Gunda, Vasudevan G. Naidoo, Shaun R. G. Temmers, Thumbi Ndung’u, Maryam Shahmanesh, Mark Siedner, Emily B. Wong, Janet Seeleyh-index 60, Thandeka Khoza, Collins Iwuji, Philippa C. Matthewsh-index 61

0
Citations
no database records one yet
0
Citations in 2026
so far
61
Leading author's h-index
Philippa C. Matthews, in QAI's scholar index
37
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Background: Hepatitis B virus (HBV) infection is endemic in many African populations, but has been neglected by funding, education, clinical infrastructure and research. High-profile international targets have been set for HBV elimination by 2030. Objectives: We here present the protocol for EVOLVE-HBV, an interdisciplinary study based at the Africa Health Research Institute aiming to quantify and characterize HBV infection in the KwaZulu-Natal (KZN) province, South Africa. The study aims to develop insights into HBV by assessing population knowledge, epidemiology, clinical features and laboratory characteristics, with the overall aim of enhancing local care pathways. Design: Study phase I is a retrospective, observational cross-sectional assessment of HBV sero-epidemiology. Phase II incorporates the prospective recruitment of adults living with HBV and HBV-negative controls from the same community. Study dates are 1 August 2023 to 31 July 2027. Methods: The study is supported by an active programme of community engagement. Phase I: banked samples are tested for HBV serum markers in a clinical diagnostic laboratory and analysed to generate weighted estimates of HBV infection, exposure and immunity. Phase II: data are collected through questionnaire, clinical assessment, biometric data, imaging using Fibroscan™ and laboratory assays including measurement of biomarkers, antiviral drug concentrations and HBV whole genome sequencing. Social scientists collect qualitative data regarding beliefs, experiences and needs of the community. Data across all themes inform a detailed picture of the sociodemographic, clinical and molecular characteristics of HBV infection. Ethics: EVOLVE-HBV is approved by the University of KZN Biomedical Research Ethics Committee in South Africa (ref. 00004495/2022), and University College London (UCL) ethics committee in the United Kingdom (ref. 23221/001). Discussion: This protocol describes a study that will inform insights into local HBV epidemiology, determine the need for scale-up of vaccination, screening and treatment, inform local policy, education and service-development and provide an evidence-based foundation for future clinical practice and translational research. Collectively, this work aims to inform improvements in clinical and public health strategies to support progress towards 2030 targets.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Philippa C. Matthews has the highest h-index among the authors (61).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (39)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (37)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 17 more references

A free account opens the rest of the citing papers and references on every paper’s page.